Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Luca Ferraro, PharmD
Therapeutic potential of palmitoylethanolamide in a transgenic animal model of Alzheimer's disease: focus on neuroinflammation and synaptic dysfunction.
A GuideStar-Rated Charity
© Copyright 2026. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).